Patent Assignment
Reel/Frame 061727/0039
Second Lien Patent Security Agreement
Recorded: 2022-10-19
Pages: 32
Assignor
INSMED INCORPORATED
Executed: 2022-10-19
Assignee
ORBIMED ROYALTY & CREDIT OPPORTUNITIES IV, LP
601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK, NEW YORK, 10022
Covered Properties
(110)
Pharmaceutical Formulations of Treprostinil Prodrugs and Methods of Use Thereof
PCT:
PCT/US2021/024077 ↗
Methods for Extracting Neutrophil Serine Proteases and Treating Dipeptidyl Peptidase 1-Mediated Conditions
PCT:
PCT/US2021/042199 ↗
Methods for Treating Newly Diagnosed Mycobacterium Avium Complex Lung Infections
PCT:
PCT/US2021/048199 ↗
Dry Powder Compositions of Treprostinil Prodrugs and Methods of Use Thereof
PCT:
PCT/US2021/057078 ↗
Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides for Treating Behaceta's Disease
PCT:
PCT/US2021/064810 ↗
Dry Powder Compositions of Glycopeptide Derivative Compounds and Methods of Use Thereof
PCT:
PCT/US2022/020890 ↗
Certain N-(1-Cyano-2-Phenylethyl)-1,4-Oxazepane-2-Carboxamides for Treating Cancer
PCT:
PCT/US2022/026769 ↗
Certain N-(1-Cyano-2-Phenylethyl)-1,4-Oxazepane-2-Carboxamides for Treating Cystic Fibrosis
PCT:
PCT/US2022/027026 ↗
In Vitro Release Assay Methods for Liposomal Aminoglycoside Formulations
PCT:
PCT/US2022/032629 ↗
Tunable Polymeric Nanoparticles for Targeted and Sustained Delivery of Glycopeptide Antibiotics
PCT:
PCT/US2022/040864 ↗
Adeno-Associated Virus Particles and Methods of Use Thereof
PCT:
PCT/US2022/074622 ↗
Fluid Droplet Production Apparatus and Method
Inhalation Therapy Device
Inhalation Therapy Device
Sustained Release of Antiinfectives
Method for Use of Igf-Binding Protein for Selective Sensitization of Target Cells in Vivo
Device for Inhalation Therapy
Recombinant Igf Expression Systems
Sustained Release of Antiinfectives
Purified Rhlgf-I/Rhlgfbp-3 Complexes and Their Method of Manufacture
Lipid-Based Compositions of Antiinfectives for Treating Pulmonary Infections and Methods of Use Thereof
Methods of Treating Pulmonary Disorders with Liposomal Amikacin Formulations
Sustained Release of Antiinfectives
Fluid Droplet Production Apparatus and Method
Therapeutic Charge Engineered Variants of Lysozyme and Methods for Using The Same to Treat Infections
Method of Treating Pulmonary Disorders with Liposomal Amikacin Formulations
Lipid-Based Compositions of Antiinfectives for Treating Pulmonary Infections and Methods of Use Thereof
Method for Treating Pulmonary Disorders with Liposomal Amikacin Formulations
Lipid-Based Compositions of Antiinfectives for Treating Pulmonary Infections and Methods of Use Thereof
Lipid-Based Compositions of Antiinfectives for Treating Pulmonary Infections and Methods of Use Thereof
Lipid-Based Compositions of Antiinfectives for Treating Pulmonary Infections and Methods of Use Thereof
Lipid-Based Compositions of Antiinfectives for Treating Pulmonary Infections and Methods of Use Thereof
Systems for Treating Pulmonary Infections
Aerosol Generator
Sustained Release of Antiinfectives
Prostacyclin Compounds, Compositions and Methods of Use Thereof
Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors
Prostacyclin Compounds, Compositions and Methods of Use Thereof
Methods for Treating Pulmonary Non-Tuberculous Mycobacterial Infections
Therapeutic Charge Engineered Variants of Lysozyme and Methods for Using Same to Treat Infections
Methods of Treating Pulmonary Disorders with Liposomal Amikacin Formulations
Method of Treating Pulmonary Disorders with Liposomal Amikacin Formulations
Unglycosylated Lysostaphin Variant Protein
Lipid-Based Compositions of Antiinfectives for Treating Pulmonary Infections and Methods of Use Thereof
Prostacyclin Compounds, Compositions and Methods of use Thereof
Lipid-Based Compositions of Antiinfectives for Treating Pulmonary Infections and Methods of Use Thereof
Lipid-Based Compositions of Antiinfectives for Treating Pulmonary Infections and Methods of Use Thereof
Lipid-Based Compositions of Antiinfectives for Treating Pulmonary Infections and Methods of Use Thereof
Deimmunized Lysostaphin and Methods of Use
Methods for Treating Pulmonary Non-Tuberculous Mycobacterial Infections
Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors
Lipid-Based Compositions of Antiinfectives for Treating Pulmonary Infections and Methods of Use Thereof
Methods of Manufacturing Treprostinil and Treprostinil Derivative Prodrugs
Methods of Treating Pulmonary Disorders with Liposomal Amikacin Formulations
Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors
Aerosol Generator
Prostacyclin Compounds, Compositions and Methods of Use Thereof
Methods for Treating Pulmonary Non-Tuberculous Mycobacterial Infections
Methods for Treating Pulmonary Non-Tuberculous Mycobacterial Infections
Methods for Treating Pulmonary Non-Tuberculous Mycobacterial Infections
Antibodies and Methods of Making Same
Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors
Methods of Manufacturing Treprostinil and Treprostinil Derivative Prodrugs
Deimmunized Lysostaphin and Methods of Use
Methods for Treating Pulmonary Non-Tuberculous Mycobacterial Infections
Lipo-Glycopeptide Cleavable Derivatives and Uses Thereof
Glycopeptide Derivative Compounds and Uses Thereof
Application:
16/615,232 →
Publication:
US 2020/0368312
Prostacyclin Compounds, Compositions and Methods of Use Thereof
Lipid-Based Compositions of Antiinfectives for Treating Pulmonary Infections and Methods of Use Thereof
Application:
16/746,205 →
Publication:
US 2020/0390758
Methods for Treating Pulmonary Non-Tuberculous Mycobacterial Infections
Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors
Dry Powder Compositions of Treprostinil Prodrugs and Methods of Use Thereof
Methods for Treating Pulmonary Non-Tuberculous Mycobacterial Infections
PHARMACEUTICAL COMPOSITIONS COMPRISING (2S)-N-{(1S)-1-CYANO-2-[4-(3-METHYL-2-OXO-2,3-DIHYDRO-1,3-BENZOXAZOL-5-yl)PHENYL]ETHYL}-1,4-OXAZEPANE-2-CARBOXAMIDE
Methods for Continuous Manufacture of Liposomal Drug Products
Methods for Treating Pulmonary Non-Tuberculous Mycobacterial Infections
Methods for the Manufacture of Liposomal Drug Formulations
Application:
17/052,070 →
Publication:
US 2021/0113467
Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors
Systems for Treating Pulmonary Infections
Application:
17/175,317 →
Publication:
US 2021/0369752
Prostacyclin Compounds, Compositions and Methods of Use Thereof
Sustained Release of Antiinfectives
Application:
17/197,867 →
Publication:
US 2022/0016150
Deimmunized Lysostaphin and Methods of Use
Lipo-Glycopeptide Cleavable Derivatives and Uses Thereof
Application:
17/295,360 →
Publication:
US 2022/0024980
Glycopeptide Derivative Compounds and Uses Thereof
Application:
17/295,370 →
Publication:
US 2021/0388028
Lipo-Glycopeptide Cleavable Derivatives and Uses Thereof
Methods of Manufacturing Treprostinil and Treprostinil Derivative Prodrugs
Application:
17/470,723 →
Publication:
US 2022/0135513
Unglycosylated Lysostaphin Variant Protein
Aerosol Generator
Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides for Treating Bronchiectasis
Application:
17/576,470 →
Publication:
US 2022/0133737
Methods and Materials for Producing Recombinant Viruses in Eukaryotic Microalgae
Methods for Treating Pulmonary Non-Tuberculous Mycobacterial Infections
Methods for Treating Pulmonary Non-Tuberculous Mycobacterial Infections
Dry Powder Compositions of Treprostinil Prodrugs and Methods of Use Thereof
Sustained Release of Antiinfectives
Application:
17/930,931 →
Publication:
US 2023/0008563
Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors
Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors
Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors
Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors
Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors
Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors
Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors
Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors
Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors
Certain N-(1-Cyano-2-Phenylethyl)-1,4-Oxazepane-2-Carboxamides for Treating Cancer
Application:
63/234,961 →
Adeno-Associated Virus Vectors and Methods of Use and Delivery Thereof
Application:
63/239,881 →
Certain N-(1-Cyano-2-Phenylethyl)-1,4-Oxazepane-2-Carboxamides for Treating Cancer
Application:
63/241,754 →
Certain N-(1-Cyano-2-Phenylethyl)-1,4-Oxazepane-2-Carboxamides for Treating Chronic Rhinosinusitis
Application:
63/273,540 →
Dry Powder Compositions of Bedaquiline and Salts and Methods of Use Thereof
Application:
63/307,373 →
Certain N-(1-Cyano-2-Phenylethyl)-1,4-Oxazepane-2-Carboxamides for Treating Hidradenitis Suppurativa
Application:
63/310,751 →
Novel DPP1 Inhibitors and Uses Thereof
Application:
63/369,750 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Merger
Jun 15, 2012
From: RIVER ACQUISITION CO.
To: TRANSAVE, INC.
Reel/Frame 028385/0357 →
Assignment of Assignor's Interest
Jun 15, 2012
From: TRANSAVE, LLC
To: INSMED INCORPORATED
Reel/Frame 028385/0474 →
Merger
Jun 15, 2012
From: TRANSAVE, INC.
To: TRANSAVE, LLC
Reel/Frame 028385/0433 →
Assignment of Assignor's Interest
Aug 7, 2013
From: TRANSAVE, LLC
To: INSMED INCORPORATED
Reel/Frame 030959/0682 →
Assignment of Assignor's Interest
Aug 7, 2013
From: BONI, LAWRENCE T.; MILLER, BRIAN S.; MALININ, VLADIMIR; LI, XINGONG
To: TRANSAVE, INC.
Reel/Frame 030958/0277 →
Merger
Aug 7, 2013
From: TRANSAVE, INC.
To: TRANSAVE, LLC
Reel/Frame 030959/0547 →
Corrective Assignment to Correct the Name of the Assignor and the Assignee on the Cover Sheet Previously Recorded on Reel 027325 Frame 0401. Assignor(S) Hereby Confirms the Name of the Assignor Is Transave, Inc. and the Name of the Assignee Is Transave, Llc.
Aug 7, 2013
From: TRANSAVE, INC.
To: TRANSAVE, LLC
Reel/Frame 030984/0214 →
Merger
Aug 21, 2013
From: TRANSAVE, INC.
To: TRANSAVE, LLC
Reel/Frame 031051/0980 →
Assignment of Assignor's Interest
Dec 3, 2013
From: TRANSAVE, LLC
To: INSMED INCORPORATED
Reel/Frame 031704/0669 →
Corrective Assignment to Correct the Receiving Party Street Address Previously Recorded at Reel: 038947 Frame: 0075. Assignor(S) Hereby Confirms the Assignment.
Jul 1, 2016
From: TRANSAVE, LLC
To: INSMED INCORPORATED
Reel/Frame 039235/0465 →
Merger
Aug 12, 2021
From: TRANSAVE, INC.
To: TRANSAVE, LLC
Reel/Frame 057162/0462 →
Assignment of Assignor's Interest
Aug 12, 2021
From: BONI, LAWRENCE T.; MILLER, BRIAN S.; MALININ, VLADIMIR
To: TRANSAVE, INC.
Reel/Frame 057162/0137 →
Merger
Aug 12, 2021
From: TRANSAVE, INC.
To: TRANSAVE, LLC
Reel/Frame 057162/0398 →
Assignment of Assignor's Interest
Nov 2, 2021
From: TRANSPORIN, INC
To: ENMODULIN, INC
Reel/Frame 058769/0528 →
Assignment of Assignor's Interest
Dec 15, 2021
From: MANGE, KEVIN; YUEN, DAYTON; JUMADILOVA, ZHANNA
To: INSMED INCORPORATED
Reel/Frame 058399/0234 →
Assignment of Assignor's Interest
Jan 12, 2022
From: DU, JU; PLAUNT, ADAM; MALININ, VLADIMIR; PARIKH, MAULIKKUMAR
To: INSMED INCORPORATED
Reel/Frame 058626/0681 →
Assignment of Assignor's Interest
May 13, 2022
From: TEPER, ARIEL; VERGARA, MARCELA MARTHA; USANSKY, HELEN HUI; MAES, ANDREA LYNN
To: INSMED INCORPORATED
Reel/Frame 059906/0449 →
Assignment of Assignor's Interest
May 23, 2022
From: CHEN, KUAN-JU; ZHANG, JIMIN; CIPOLLA, DAVID
To: INSMED INCORPORATED
Reel/Frame 059992/0499 →
Assignment of Assignor's Interest
May 23, 2022
From: PLAUNT, ADAM; MALININ, VLADIMIR
To: INSMED INCORPORATED
Reel/Frame 059992/0669 →
Assignment of Assignor's Interest
May 23, 2022
From: ZHANG, JIMIN
To: INSMED INCORPORATED
Reel/Frame 059992/0583 →
Assignment of Assignor's Interest
May 23, 2022
From: BASSO, JESSICA; ZHANG, JIMIN; CIPOLLA, DAVID
To: INSMED INCORPORATED
Reel/Frame 059992/0557 →
Assignment of Assignor's Interest
May 23, 2022
From: KONICEK, DONNA M.; GHARSE, SACHIN; PLAUNT, ADAM J.; SABNIS, ARMUTA
To: INSMED INCORPORATED
Reel/Frame 059992/0735 →
Assignment of Assignor's Interest
Jun 13, 2022
From: TEPER, ARIEL; VERGARA, MARCELA MARTHA; USANSKY, HELEN HUI; MAES, ANDREA LYNN
To: INSMED INCORPORATED
Reel/Frame 060175/0335 →
Assignment of Assignor's Interest
Oct 11, 2022
From: SHALER, TONI
To: INSMED INCORPORATED
Reel/Frame 061383/0220 →
Patent Security Agreement
Oct 20, 2022
From: INSMED INCORPORATED
To: BIOPHARMA CREDIT PLC
Reel/Frame 061735/0875 →